nohealthproblemsnews.com
Home »
The 6-month subcutaneously injectable leuprolide acetate (Fensolvi, Tolmar Pharmaceuticals) effectively and safely treats children with central precocious (early) puberty, research […] Length of hospital stay and the need for intensive care for pediatric COVID-19 patients with multisystem inflammatory syndrome in children […]
A Major Change? 6-Monthly Leuprolide for Central Precocious Puberty
MIS-C: Where Patients First Seek Care May Not Affect Outcomes
